DN
Dubois-Stringfellow Nathalie
Insider track record
OtherAcross 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Dubois-Stringfellow Nathalie. Director active across 1 company, notably Sangamo Therapeutics, INC. Aggregated, 13 reports have been recorded. History available since 24 February 2023. The latest transaction was filed on 25 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations13 total
4,036 shares@ US$0.17430.0004% mcap0.3% of flowCommon StockSEC:0001947007-26-000012:0
31,866 shares@ US$0.776312.0% of flowCommon StockSEC:0001415889-25-011281:0
1,792 shares@ US$1.000.9% of flowCommon StockSEC:0001415889-25-005707:0
129,593 shares@ US$1.1578.7% of flowCommon StockSEC:0001415889-25-002020:0
1,787 shares@ US$1.881.8% of flowCommon StockSEC:0001415889-24-027704:0
1,787 shares@ US$0.860.8% of flowCommon StockSEC:0001415889-24-022307:0
1,787 shares@ US$0.600.5% of flowCommon StockSEC:0001415889-24-014798:0
5,474 shares@ US$1.133.1% of flowCommon StockSEC:0001415889-24-005549:0
712,500 shares0Common StockSEC:0001415889-24-001755:0
1,462 shares@ US$0.38210.3% of flowCommon StockSEC:0001209191-23-056777:0
1,462 shares@ US$0.770.6% of flowCommon StockSEC:0001209191-23-047579:0
1,462 shares@ US$1.331.0% of flowCommon StockSEC:0001209191-23-032909:0
53,438 shares0Common StockSEC:0001209191-23-016393:0